Deng Kim Boillat Blanco

156 SCIENTIFIC SESSIONS September 9-12 | G3-1545 Acute Childhood Encephalitis in Israel: Etiology, Epidemiology and Clinical Characteristics

G. Grisaru

1 , N. Yanai 1 , S. Reif 1 , G. Paret 2 ; 1 Dana Children’s Hosp. Sourasky Med. Ctr., Tel-Aviv, Israel, 2 Safra Children’s Hosp., Tel-Aviv, Israel. G3-1546 The Betaherpesviruses in Children with Cancer

J. Goldfarb

1 , N. Borges 2 , L. K. Gowans 1 , D. Kohn 3 , S. Worley 4 , B. Yen- Lieberman 1 , D. Lach 1 , L. Danziger-Isakov 1 , P. Pellett 5 ; 1 Cleveland Clinic Children’s Hosp., Cleveland, OH, 2 Children’s Hosp. Pittsburgh, PA, 3 Cleve- land Clinic, Cleveland, OH, 4 Cleveland Clinic Biostatistics and Quanti, Cleveland, OH, 5 Wayne State Univ. Sch. of Med., Cleveland, OH. G3-1547 Bloodstream Infections at a European Pediatric Cancer Center: Trends in Epidemiology and Outcome between 2000 and 2010 M. Floeth, G. Lubritz, A. Tragiannidis, A. Kremer, G. Goletz, R. Koeck, K. Becker, A. H. Groll; Univ. Hosp., Muenster, Germany. G3-1548 Clinical and Epidemiological Aspects of Severe Form of the Acute Respiratory Infection at Children

Z. Djolbunova; Kyrgyz State Med. Academy Dept. of Child Infectious Diseases, Bishkek, Kyrgyzstan.

G3-1549 Influenza C Virus ICV Infection in Children Aged 5 Years with Lower Respiratory Tract Infection RTI S. Esposito, A. Scala, C. Daleno, S. Consolo, E. Baggi, E. Fossali, N. Principi; Fondazione IRCCS Policlinico, Univ. degli Studi di Milano, Milan, Italy. G3-1550 Influenza-Associated Complications in Children: The Impact of Antiviral Treatment

P. Spagnuolo

1 , M. Zhang 2 , S. Liu 2 , J. Liu 2 , Y. Xu 3 , J. Han 3 , E. Chen 3 , L. Shi 2 ; 1 Case Western Reserve Univ., Cleveland, OH, 2 Tulane Univ., New Orleans, LA, 3 Genentech, Inc., South San Francisco, CA. G3-1551 Risk Factors for Hospitalization of Childhood Community- Acquired Pneumonia CAP: A Multi-Center Study

V. Spoulou

1 , T. Lagousi 1 , J. D. Domingo 2 , M. Tortajada 2 , D. Greenberg 3 , O. Falup-Pecurariu 4 , S. Esposito 5 , V. Usonis 6 , F. Rodrigues 7 , G. Syrogian- nopoulos 8 ; 1 Agia Sophia Children’s Hosp., Athens, Greece, 2 CSISP, Valencia, Spain, 3 Soroka Univ. Med. Ctr., Beer-Sheva, Israel, 4 Transilvania Univ., Ro- mania, 5 Fondazione IRCCS Granda Ospedale Maggiore Policlinico, Milan, Italy, 6 Clinic of Children’s Diseases, Vilnius, Lithuania, 7 Hosp. Pediátrico de Coimbra, Coimbra, Portugal, 8 Gen. Univ. Hosp., Larissa, Greece. G3-1552 Inpatients with Tuberculosis at a Paediatric Hospital in Buenos Aires C. Cerqueiro, N. Rivas, G. Manonelles, A. Burkett, A. Caratozzolo, A. DeMena, N. Sordelli, C. Ceccoli, A. Fallo, E. Lopez; Hosp. de Niños Dr Ricardo Gutiérrez, Buenos Aires, Argentina. G3-1553 Adherence to Recommendations on Lyme Disease Testing and Treatment in Children S. Esposito, E. Baggi, S. Sferrazza, S. Bosis, A. Zampiero, L. Terranova, E. Danieli, W. Peves Rios, N. Principi, SITIP Lyme Disease Study Group; Fondazione IRCCS Policlinico, Univ. degli Studi di Milano, Milan, Italy. G3-1554 Clinical and Microbiological Characteristics of Invasive Group a Streptococcal Infections Before and After Implementa- tion of a Varicella Vaccine Program in Quebec

J. Frere

1 , P. Bidet 2 , B. Tapiero 1 , F. Rallu 1 , S. Liguori 2 , P. Minodier 3 , E. Bingen 2 , P. Ovetchkine 1 ; 1 CHU Sainte-Justine, Montreal, Canada, 2 Hosp. Robert Debre, Paris, France, 3 Hosp. Nord, Marseille, France. G3-1555 Increasing Incidence and Sociodemographic Variation in Community-Onset Staphylococcus aureus Skin and Soft Tissue Infections in New Zealand Children

D. A. Williamson

1 , M. G. Baker 2 , S. A. Roberts 3 , S. R. Ritchie 1 ; 1 Univ. of Auckland, Auckland, New Zealand, 2 Univ. of Otago, Wellington, New Zealand, 3 Auckland District Hlth. Board, Auckland, New Zealand. G3-1556 Should Live Vaccines be Contraindicated in Immunosup- pressed Patient? VZV Immunization in Pediatric Liver Transplant Recipients L. F. Pittet, V. A. McLin, L. Kaiser, B. E. Wildhaber, D. C. Belli, C. Siegrist, K. M. Posfay-Barbe; Univ. Hosp. of Geneva, Geneva, Switzerland. G3-1557 Children Born to Renal Transplanted Women: Immunos- supressor Effects at Birth and at 8 Months of Age E. Ono, P. O. Viana, M. I. S. Dinelli, A. M. N. dos Santos, L. G. Oliveira, J. L. Sato, N. Sass, M. I. de Moraes-Pinto; Federal Univ. of Sao Paulo, Sao Paulo, Brazil. G3-1558 Vancomycin-Associated Acute Kidney Injury in Children

C. A. Knoderer

1 , K. C. Lyon Candidate 1 , M. M. Veverka Candidate 1 , K. R. Nichols 1 , A. C. Wilson 2 ; 1 Butler Univ. Coll. of Pharmacy and Hlth. Sci., Indianapolis, IN, 2 Indiana Univ. Sch. of Med., Indianapolis, IN. G3-1559 A Point Prevalence Survey PPS of Neonatal and Paediatric Antifungal Use in Europe

C. Bertaina

1 , K. Doerholt 2 , J. Bielicki 3 , A. Versporten 4 , H. Goossens 4 , I. Lutsar 5 , M. Sharland 2,3 ; 1 Regina Margherita Hosp., Turin, Italy, 2 St George’s Hosp. NHS Trust, London, United Kingdom, 3 St George’s Univ., London, United Kingdom, 4 Univ. of Antwerp-Campus Drie Eiken, Antwerp, Bel- gium, 5 Univ. of Tartu, Tartu, Estonia. G3-1560 Micafungin Safety in Pediatric Patients in Clinical Practice A. C. Arrieta, N. ASshouri, D. J. Nieves, J. Singh, F. Adler, O. Vargas-Shirai- shi; CHOC Children’s Hosp. of Orange County, Orange, CA. G3-1561 Safety of Micafungin in Infants Less Than 90 Days of Age D. J. Nieves, N. Ashouri, F. Adler-Shohet, J. Singh, A. Arrieta, O. Vargas- Shiraishi; Children’s Hosp., Orange, CA. G3-1562 Surveillance Study of Streptococcus pneumoniae Clinical Iso- lates among Ontario Children in Canada 2007-2011: Epidemiol- ogy, Serotyping, Genotyping and Antibiotic Resistance Patterns

W. Deng

1 , R. Mackenzie 1 , G. Arya 2 , G. Macmullin 2 , S. Pong 3 , D. Pillai 4 , J. Gubbay 2 , D. Low 1 ; 1 Dept. of Lab. Med. and Pathobiology, Univ. of Toronto, Toronto, Canada, 2 Publ. Hlth. Ontario Lab., Toronto, Canada, 3 Mount Sinai Hosp., Toronto, Canada, 4 Dept. of Lab. Med. and Pathobiology, Univ. of Calgary, Calgary, Canada. G3-1563 Real-Time PCR-Based Detection of Bordetella pertussis in Mexican Children and Their Contacts: A Multicenter Study A. Aquino, G. Martinez-Leyva, P. Saltigeral, W. Dominguez, E. Lucas, P. Arzate, A. Lara, N. Gonzalez, S. Garcia de la Puente, A. De Colsa; Inst. Natl. De Pediatria, Mexico City, Mexico. Late-breaker presentations are listed behind the Late-breaker tab of the Final Program. 157 TUESDAY SCIENTIFIC SESSIONS Final Program ------------------------------------------------------------------------ 179 H Poster Session HIV-I Pathogenesis and Predictors of Antiretroviral Response in Treatment and Prevention Tuesday, 11:15 a.m.–1:15 p.m. . . . . . . . . . . . . . . . . . . . Halls A-C Presentations: H-1564 CD4 Slope as a Predictor for Immunologic Recovery in Ad- vanced Human Immunodeficiency Virus-Infected Patients

K. Kim

1 , J. Yi 2 , S. Lee 1 ; 1 Pusan Natl. Univ. Hosp., Busan, Korea, Republic of, 2 Pusan Natl. Univ. Yangsan Hosp., Yangsan, Gyeongsangnam-do, Korea, Republic of. H-1565 Factors Associated with Immune Discordance in HIV-Infect- ed Patients Receiving Antiretroviral Therapy with Complete Viral Suppression P. Mingbunjerdsuk, N. Asdamongkol, S. Sungkanuparph; Faculty of Med. Ramathibodi Hosp., Mahidol Univ., Bangkok, Thailand. H-1566 Persistent Low-Level Viraemia in HIV-1-Infected Patients: Swiss HIV Cohort Study

N. Boillat Blanco

1 , K. Darling 1 , F. Schöni-Affolter 2 , H. Günthard 3 , R. Fulchini 4 , M. Rougemont 5 , E. Bernasconi 6 , D. Vuichard 7 , H. Furrer 8 , O. Clerc 1 , M. Cavassini 1 ; 1 Univ., Lausanne, Switzerland, 2 SHCS Data Ctr., Lausanne, Switzerland, 3 Univ., Zurich, Switzerland, 4 Hosp., St. Gallen, Swit- zerland, 5 Univ., Geneva, Switzerland, 6 Hosp., Lugano, Switzerland, 7 Univ., Basel, Switzerland, 8 Univ., Bern, Switzerland. H-1567 CD4CD8 Ratio Relations with Immune Activation, Bacte- rial Translocation and Latent HIV-1 Reservoir in Virally Sup- pressed HIV-Infected Subjects

S. Serrano-Villar